Si Y, Zhang H, Peng P, Zhu C, Shen J, Xiong Y
Cancer Sci. 2021; 112(12):4867-4882.
PMID: 34609770
PMC: 8645722.
DOI: 10.1111/cas.15151.
Gilson T, Culleton S, Xie F, DeSmet M, Androphy E
J Virol. 2020; 94(16).
PMID: 32493825
PMC: 7394896.
DOI: 10.1128/JVI.00590-20.
DeSmet M, Jose L, Isaq N, Androphy E
J Virol. 2019; 93(10).
PMID: 30842331
PMC: 6498050.
DOI: 10.1128/JVI.01801-18.
Thomas Y, Androphy E
J Virol. 2017; 92(3).
PMID: 29142126
PMC: 5774875.
DOI: 10.1128/JVI.01912-17.
Culleton S, Kanginakudru S, DeSmet M, Gilson T, Xie F, Wu S
J Virol. 2016; 91(2).
PMID: 27807239
PMC: 5215344.
DOI: 10.1128/JVI.01854-16.
The Replicative Consequences of Papillomavirus E2 Protein Binding to the Origin Replication Factor ORC2.
DeSmet M, Kanginakudru S, Rietz A, Wu W, Roden R, Androphy E
PLoS Pathog. 2016; 12(10):e1005934.
PMID: 27701460
PMC: 5049798.
DOI: 10.1371/journal.ppat.1005934.
Exchange Factor TBL1 and Arginine Methyltransferase PRMT6 Cooperate in Protecting G Protein Pathway Suppressor 2 (GPS2) from Proteasomal Degradation.
Huang J, Cardamone M, Johnson H, Neault M, Chan M, Floyd Z
J Biol Chem. 2015; 290(31):19044-54.
PMID: 26070566
PMC: 4521029.
DOI: 10.1074/jbc.M115.637660.
The viral E8^E2C repressor limits productive replication of human papillomavirus 16.
Straub E, Dreer M, Fertey J, Iftner T, Stubenrauch F
J Virol. 2013; 88(2):937-47.
PMID: 24198405
PMC: 3911659.
DOI: 10.1128/JVI.02296-13.
The papillomavirus E2 proteins.
McBride A
Virology. 2013; 445(1-2):57-79.
PMID: 23849793
PMC: 3783563.
DOI: 10.1016/j.virol.2013.06.006.
The HPV E2-Host Protein-Protein Interactions: A Complex Hijacking of the Cellular Network.
Muller M, Demeret C
Open Virol J. 2013; 6:173-89.
PMID: 23341853
PMC: 3547520.
DOI: 10.2174/1874357901206010173.
Acetylation of conserved lysines in bovine papillomavirus E2 by p300.
Quinlan E, Culleton S, Wu S, Chiang C, Androphy E
J Virol. 2012; 87(3):1497-507.
PMID: 23152516
PMC: 3554136.
DOI: 10.1128/JVI.02771-12.
Type-specific interaction between human papillomavirus type 58 E2 protein and E7 protein inhibits E7-mediated oncogenicity.
Wang X, Qi M, Yu X, Yuan Y, Zhao W
J Gen Virol. 2012; 93(Pt 7):1563-1572.
PMID: 22442110
PMC: 3542735.
DOI: 10.1099/vir.0.039354-0.
Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression.
Bellanger S, Tan C, Xue Y, Teissier S, Thierry F
Am J Cancer Res. 2011; 1(3):373-389.
PMID: 21968515
PMC: 3180061.
Small molecule inhibitors of human papillomavirus protein - protein interactions.
DAbramo C, Archambault J
Open Virol J. 2011; 5:80-95.
PMID: 21769307
PMC: 3137155.
DOI: 10.2174/1874357901105010080.
Interaction of the papillomavirus E8--E2C protein with the cellular CHD6 protein contributes to transcriptional repression.
Fertey J, Ammermann I, Winkler M, Stoger R, Iftner T, Stubenrauch F
J Virol. 2010; 84(18):9505-15.
PMID: 20631145
PMC: 2937640.
DOI: 10.1128/JVI.00678-10.
G protein pathway suppressor 2 (GPS2) is a transcriptional corepressor important for estrogen receptor alpha-mediated transcriptional regulation.
Cheng X, Kao H
J Biol Chem. 2009; 284(52):36395-36404.
PMID: 19858209
PMC: 2794755.
DOI: 10.1074/jbc.M109.062109.
Papillomavirus E6 proteins.
Howie H, Katzenellenbogen R, Galloway D
Virology. 2008; 384(2):324-34.
PMID: 19081593
PMC: 2674106.
DOI: 10.1016/j.virol.2008.11.017.
Modification of papillomavirus E2 proteins by the small ubiquitin-like modifier family members (SUMOs).
Wu Y, Roark A, Bian X, Wilson V
Virology. 2008; 378(2):329-38.
PMID: 18619639
PMC: 2562504.
DOI: 10.1016/j.virol.2008.06.008.
Inhibition of transcription and DNA replication by the papillomavirus E8-E2C protein is mediated by interaction with corepressor molecules.
Ammermann I, Bruckner M, Matthes F, Iftner T, Stubenrauch F
J Virol. 2008; 82(11):5127-36.
PMID: 18353941
PMC: 2395219.
DOI: 10.1128/JVI.02647-07.
G-protein pathway suppressor 2 (GPS2) interacts with the regulatory factor X4 variant 3 (RFX4_v3) and functions as a transcriptional co-activator.
Zhang D, Harry G, Blackshear P, Zeldin D
J Biol Chem. 2008; 283(13):8580-90.
PMID: 18218630
PMC: 2365754.
DOI: 10.1074/jbc.M708209200.